Portal de Periódicos da CAPES

Resveratrol bioavailability and toxicity in humans

2009; Wiley; Volume: 54; Issue: 1 Linguagem: Inglês

10.1002/mnfr.200900437

1613-4133

Charles‐Henry Cottart, Valérie Nivet‐Antoine, Christelle Laguillier, Jean‐Louis Beaudeux,

Coffee research and impacts

Numerous data are now available on the beneficial properties of the polyphenolic compound resveratrol including its anti-inflammatory and antitumor effects. However, few studies have been performed with resveratrol in humans, and the results of these studies appear fragmentary and sometimes contradictory due to variations in conditions of administration, protocols and methods of assessment. This review article presents the results of recent studies investigating the pharmacokinetics, bioavailability, and toxicity of resveratrol in humans. Resveratrol is well absorbed, rapidly metabolized, mainly into sulfo and glucuronides conjugates which are eliminated in urine. Resveratrol seems to be well tolerated and no marked toxicity was reported. These data are important in the context of human efficacy studies, and they provide further support for the use of resveratrol as a pharmacological drug in human medicine.